In terms of classic chemotherapeutic drugs, we found that the use of G9a inhibitor UNC0638 in drug-resistant cells can significantly reduce GCLC expression in cisplatin resistant HNSCC. The gene discussed is EHMT2; the disease is head and neck squamous cell carcinoma.